Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.

Podobne zapisy

• Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.
  od: McCarroll, D R, i wsp.
  Wydane: (1985)
• Beta-adrenoceptor antagonists enhance white blood cell aggregation in patients with ischaemic heart disease.
  od: Bridges, A B, i wsp.
  Wydane: (1992)
• Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence
  od: Buchtele, Nina, i wsp.
  Wydane: (2018)
• von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.
  od: Nordborg, E, i wsp.
  Wydane: (1991)
• Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.
  od: Fujimoto, T, i wsp.
  Wydane: (1982)